Abstract
Using a feasible method, we generated a small focused library of structurally related alkenylcoumarins. These compounds were evaluated as potential antitumoral agents against Taq DNA polymerase. 6-(pent-4-enyloxy)-coumarin (7) IC50 = 48.33 ± 2.85 μM was defined as a small molecule able to disturb DNA replication. Docking and Molecular Dynamic Simulations suggest an active-site binding. Structure/activity relationship was reasonably established. Compound 7 represents a potential structure for further studies in the development of new anti-cancer DNA/polymerase binding agents.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bernauer J, Janin J, Poupon J (2007) A new protein–protein docking scoring function based on interface residue properties. Bioinformatics 23:555–562
Garro HA, García C, Martín VS, Tonn CE, Pungitore CR (2015a) A new iridoid, verbascoside and derivatives with inhibitory activity against Taq DNA polymerase. Bioorg Med Chem Lett 25:914–918
Garro HA, Pungitore CR (2015b) Coumarins as potential inhibitors of DNA polymerases and reverse transcriptases. Searching new antiretroviral and antitumoral drugs. Curr Drug Discov Technol 12:66–79
Garro HA, Manzur MJ, Ciuffo GM, Tonn CE, Pungitore CR (2014a) Inhibition of reverse transcriptase and Taq DNA polymerase by compounds possessing the coumarin framework. Bioorg Med Chem Lett 24:760–764
Garro HA, García C, Martín VS, Tonn CE, Pungitore CR (2014b) Chemistry and biological activity of coumarins at molecular level. Nat Prod Comm 9:1091–1094
Garro HA, Petroselli G, Pungitore CR, Tonn CE, Erra-Balsells R (2015c) Synthesis and characterization of conjugated olygomers by acetone self-condensation end-functionalized with 4-hydroxycoumarin. J Mater Environ Sci 6:1137–1141
Ghiano DG, de la Iglesia A, Liu N, Tonge PJ, Morbidoni HR, Labadie GR (2017) Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives. Eur J Med Chem 125:842–852
Gutiérrez LJ, Angelina E, Gyebrovszki A, Fülöp L, Peruchena N, Baldoni HA, Penke B, Enriz RD (2017) New small-size peptides modulators of the exosite of BACE1 obtained from a structure-based design. J Biomol Struct Dyn 35:413–426
Izaguirre JA, Catarello DP, Wozniak JM, Skeel RD (2001) Langevin stabilization of molecular dynamics. J Chem Phys 114:2009–2014
Kostova I (2007) Biologically active coumarins as inhibitors of HIV-1. Futur. HIV Ther 1:315–329
Kostova I, Genova P, Argirova R (2006) Structure-activity relationships of synthetic coumarins as HIV-1 inhibitors. Bioinorg Chem Appl 1:1–9
Li B (2012) Protein docking prediction using predicted protein-protein interface. Bioinformatics 13:1–17
Liu R, Li X, Lam KS (2017) Combinatorial chemistry in drug discovery. Curr Opin Chem Biol 38:117–126
Martin OA, Garro HA, Kurina-Sanz MB, Pungitore CR, Tonn CE (2011) In silico study of the inhibition of DNA polymerase by a novel catalpol derivative. J Mol Model 17:2717–2723
Mizushina Y, Akihisa T, Ukiya M, Hamasaki Y, Murakami-Nakai C, Kuriyama I, Takeuchi T, Sugawara F, Yoshida H (2005) Structural analysis of isosteviol and related compounds as DNA polymerase and DNA topoisomerase inhibitors. Life Sci 77:2127–2140
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, OlsonAJ (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 16:2785–2791
Olmedo D, Bedoya LM, López-Pérez JL, Del Olmo E, Muñoz E, Alcamí J, Gupta MP, San Feliciano A (2012) 3-Phenylcoumarins as inhibitors of HIV-1 replication. Molecules 17:9245–9257
Pungitore CR (2014) Natural products, synthetic and non-nucleoside compounds as inhibitors of enzymes related to DNA: Update 2013. Curr Enzym Inhib 10:13–38
Rayati S, Nejabat F (2016) Catalytic properties of the homologous series of the β-brominated-pyrrole manganese(III) tetraphenylporphyrins. Polyhedron 104:52–57
Stefanou V, Melagraki G, Afantitis A, Athanasellis G, Igglessi-Markopoulou O, McKee V, Markopoulos J (2011) Functionalized 4-hydroxy coumarins: novel synthesis, crystal structure and DFT calculations. Molecules 16:384–402
Vega-Hissi E, Tosso R, Enriz RD, Gutiérrez LJ (2015) Molecular insight into the interaction mechanisms of inhibitors (R)-1t and (S)-1m with BACE1 protease: QM/MM investigations. Int J Quantum Chem 115:389–397
Venugopala KN, Odhav B (2013) Review on natural coumarin lead compounds for their pharmacological activity. J Biomed Biotechnol 1:2–14
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174
Wijkmans JC, Beckett RP (2002) Combinatorial chemistry in anti-infectives research. Drug Discov Today 7:126–132
Acknowledgements
This research was supported by CONICET (PIP 00360) and UNSL (PROICO 02/2516). EFB thank CONICET for doctoral fellowship. HAG thank for post-doctoral position in the Max Planck Laboratory for Structural Biology, Chemistry, and Molecular Biophysics of Rosario (MPLbioR). We wish to thank to Lic. M. Ferrari, Dr. C. Ardanáz, and Dr. G. Labadie for their help. Also, we wish to thank to Dra. C. García and Prof. V. Martín from IUBO (Spain) for their help in the use of HRMS. We wish specially thank to Drs. L. Mascotti and M. Juri-Ayub for DNA material gently provided. We appreciate revision of the manuscript by staff from the “Instituto de Lenguas, Universidad Nacional de San Luis”. This work is a part of the doctoral thesis of EFB.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Bruna-Haupt, E., Garro, H.A., Gutiérrez, L. et al. Collection of alkenylcoumarin derivatives as Taq DNA polymerase inhibitors: SAR and in silico simulations. Med Chem Res 27, 1432–1442 (2018). https://doi.org/10.1007/s00044-018-2160-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-018-2160-6